Tumors now classified as glioblastoma (formerly “primary GBM”) typically present de novo and exhibit epidermal growth factor receptor (EGFR) amplification, PTEN mutations, and chromosome 10 loss [3,4,5]. The gene discussed is EGFR; the disease is glioblastoma.